Evidence map›Paper›PMID 34786548›Full record

ReviewBrain hemorrhages2021

The relationship between COVID-19 infection and intracranial hemorrhage: A systematic review.

Samuel R Daly, Anthony V Nguyen, Yilu Zhang, Dongxia Feng, Jason H Huang

Abstract readReview
In one paragraph

Review in Brain hemorrhages, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Stroke and COVID-19: An Umbrella Review.Archives of academic emergency medicine · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samuel R DalyDepartment of Neurosurgery, Baylor Scott and White Health, Scott and White Medical Center, Temple, TX, USA.
Anthony V NguyenDepartment of Neurosurgery, Baylor Scott and White Health, Scott and White Medical Center, Temple, TX, USA.
Yilu ZhangDepartment of Neurosurgery, Baylor Scott and White Health, Scott and White Medical Center, Temple, TX, USA.
Dongxia FengDepartment of Neurosurgery, Baylor Scott and White Health, Scott and White Medical Center, Temple, TX, USA.
Jason H HuangDepartment of Neurosurgery, Baylor Scott and White Health, Scott and White Medical Center, Temple, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn addition to the deleterious effects Covid-19 has on the pulmonary and cardiovascular systems, COVID-19 can also result in damage to the nervous system. This review aims to explore current literature on the association between COVID-19 and intracranial hemorrhage (ICH).

methodsWe conducted a systematic review of PubMed for literature published on COVID-19 and ICH. Ninety-four of 295 screened papers met inclusion criteria.

resultsThe literature addressed incidence and mortality of ICH associated with Covid-19. It also revealed cases of COVID-19 patients with subarachnoid hemorrhage, intraparenchymal hemorrhage, subdural hematomas, and hemorrhage secondary to cerebral venous thrombosis and ischemic stroke. ICH during COVID-19 infections was associated with increased morbidity and mortality. Risk factors for ICH appeared to be therapeutic anticoagulation, ECMO, and mechanical ventilation. Outcomes varied widely, depending on the severity of COVID-19 infection and neurologic injury.

conclusionAlthough treatment for severe Covid-19 infections is often aimed at addressing acute respiratory distress syndrome, vasculopathy, and coagulopathy, neurologic injury can also occur. Evidence-based treatments that improve COVID-19 mortality may also increase risk for developing ICH. Providers should be aware of potential neurologic sequelae of COVID-19, diagnostic methods to rule out other causes of ICH, and treatment regimens.

Indexed as

Cerebral Venous Sinus ThrombosisCerebral Venous ThrombosisCovid-19Hemorrhagic InfarctIntracranial HemorrhageIntraparenchymal HemorrhageSARS-CoV-2Subarachnoid Hemorrhage

Identifiers

PMID34786548
PMCPMC8582085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.